Cardiovascular Systems CFO Laurence L. Betterley Sells 5,725 Shares (CSII)
Cardiovascular Systems (NASDAQ:CSII) CFO Laurence L. Betterley sold 5,725 shares of Cardiovascular Systems stock on the open market in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $29.28, for a total value of $167,628.00. Following the completion of the sale, the chief financial officer now directly owns 205,319 shares of the company’s stock, valued at approximately $6,011,740. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Cardiovascular Systems (NASDAQ:CSII) traded down 0.10% during mid-day trading on Friday, hitting $29.39. The stock had a trading volume of 45,783 shares. Cardiovascular Systems has a 52-week low of $18.83 and a 52-week high of $37.73. The stock’s 50-day moving average is $28.94 and its 200-day moving average is $30.41. The company’s market cap is $909.9 million.
Cardiovascular Systems (NASDAQ:CSII) last released its earnings data on Wednesday, August 6th. The company reported ($0.31) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.28) by $0.03. The company had revenue of $39.56 million for the quarter, compared to the consensus estimate of $37.21 million. The company’s quarterly revenue was up 37.3% on a year-over-year basis. On average, analysts predict that Cardiovascular Systems will post $-1.11 earnings per share for the current fiscal year.
A number of research firms have recently commented on CSII. Analysts at Benchmark Co. raised their price target on shares of Cardiovascular Systems from $38.00 to $42.00 in a research note on Thursday, August 7th. They now have a “buy” rating on the stock. Analysts at Needham & Company LLC raised their price target on shares of Cardiovascular Systems from $37.00 to $38.00 in a research note on Thursday, August 7th. They now have a “strong-buy” rating on the stock. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $40.67.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.